Part 9: The Challenges of Developing Vaccines and Treatments for COVID-19

In this webinar, our expert speakers turn their attention to challenges of doing research on the COVID-19 pandemic. They discuss:

• The remdesivir development pathway and the experience of designing and conducting clinical trials in a brand-new disease without the benefit of medical guidance or regulatory precedent
• The status and future of prophylactic vaccine development for COVID-19
• The ethical issues of human challenge studies, which can speed vaccine development timelines but require careful consideration because they would intentionally expose study volunteers to COVID-19